Bryan Chadwick Pridgen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residential Treatment | 2 | 2017 | 113 | 0.470 |
Why?
|
| Safety | 1 | 2010 | 1179 | 0.250 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1402 | 0.220 |
Why?
|
| User-Computer Interface | 1 | 2010 | 1432 | 0.220 |
Why?
|
| Internet | 1 | 2010 | 3074 | 0.150 |
Why?
|
| Self-Injurious Behavior | 2 | 2017 | 469 | 0.120 |
Why?
|
| Play Therapy | 1 | 2013 | 17 | 0.120 |
Why?
|
| Receptors, Interleukin | 3 | 2000 | 245 | 0.110 |
Why?
|
| Family Therapy | 1 | 2013 | 210 | 0.100 |
Why?
|
| Risperidone | 1 | 2013 | 383 | 0.100 |
Why?
|
| Citalopram | 1 | 2013 | 403 | 0.090 |
Why?
|
| Risk-Taking | 2 | 2016 | 990 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 607 | 0.080 |
Why?
|
| Suicide, Attempted | 1 | 2016 | 1224 | 0.080 |
Why?
|
| Judgment | 1 | 2010 | 280 | 0.080 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 1262 | 0.070 |
Why?
|
| Interleukin-8 | 3 | 2000 | 695 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2000 | 671 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2017 | 3759 | 0.060 |
Why?
|
| Antigens, CD | 3 | 2000 | 4028 | 0.060 |
Why?
|
| Interview, Psychological | 2 | 2017 | 817 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2017 | 3161 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2010 | 1162 | 0.050 |
Why?
|
| Social Support | 1 | 2010 | 2145 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2000 | 118 | 0.040 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 1999 | 94 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 291 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 3102 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 1999 | 277 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 1999 | 962 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 262 | 0.040 |
Why?
|
| Chemotaxis | 1 | 1999 | 602 | 0.040 |
Why?
|
| Receptors, Interleukin-8A | 3 | 2000 | 45 | 0.030 |
Why?
|
| Case Management | 1 | 2017 | 285 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 6050 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 1010 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1999 | 1436 | 0.030 |
Why?
|
| Education, Special | 1 | 2013 | 87 | 0.030 |
Why?
|
| Family Conflict | 1 | 2013 | 95 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1999 | 1231 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2013 | 178 | 0.030 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 180 | 0.020 |
Why?
|
| Adolescent | 3 | 2017 | 86713 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2881 | 0.020 |
Why?
|
| Phospholipase C beta | 2 | 2000 | 49 | 0.020 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2000 | 60 | 0.020 |
Why?
|
| Type C Phospholipases | 2 | 2000 | 292 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 1279 | 0.020 |
Why?
|
| Phosphorylation | 4 | 2000 | 8414 | 0.020 |
Why?
|
| Psychometrics | 1 | 2017 | 3014 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6352 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2013 | 893 | 0.020 |
Why?
|
| Neutrophils | 1 | 1998 | 3729 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8660 | 0.020 |
Why?
|
| Inpatients | 1 | 2016 | 2549 | 0.020 |
Why?
|
| Isoenzymes | 2 | 2000 | 1722 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8721 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2013 | 1873 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 73094 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12250 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2473 | 0.010 |
Why?
|
| Cell Line | 3 | 2000 | 16004 | 0.010 |
Why?
|
| Receptors, CCR1 | 1 | 2000 | 33 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 155 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1999 | 177 | 0.010 |
Why?
|
| Receptors, Formyl Peptide | 1 | 1999 | 146 | 0.010 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 1998 | 15 | 0.010 |
Why?
|
| Rats | 3 | 2000 | 24248 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 1999 | 294 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 821 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1998 | 221 | 0.010 |
Why?
|
| Humans | 7 | 2017 | 752741 | 0.010 |
Why?
|
| Phospholipase D | 1 | 1998 | 70 | 0.010 |
Why?
|
| Complement C5a | 1 | 1998 | 107 | 0.010 |
Why?
|
| Exocytosis | 1 | 1999 | 352 | 0.010 |
Why?
|
| Signal Transduction | 2 | 1998 | 23512 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1998 | 292 | 0.010 |
Why?
|
| Depression | 1 | 2016 | 7876 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13364 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 673 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23554 | 0.010 |
Why?
|
| Endocytosis | 1 | 2000 | 987 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 1998 | 521 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10422 | 0.010 |
Why?
|
| Male | 3 | 2017 | 354311 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 6482 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6233 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5882 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 2927 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6624 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13778 | 0.000 |
Why?
|
| Female | 2 | 2017 | 385090 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 18050 | 0.000 |
Why?
|
| Child | 1 | 2013 | 78594 | 0.000 |
Why?
|
| Calcium | 1 | 1998 | 5774 | 0.000 |
Why?
|
| Animals | 3 | 2000 | 169600 | 0.000 |
Why?
|